Making Scotland the ‘Silicon Valley of Precision Medicine’
In August 2019, the Scottish Government held a special event at Scotland House, London, focussing on Scotland’s unique strengths in Precision Medicine.
The event seen a wide-ranging discussion on how collaboration between the “triple-helix” of industry, NHS and academia, can see Scotland lead the world with the implementation of Precision Medicine. A field which has the potential to revolutionise healthcare, and make a major contribution to our economy, as an industry projected to be worth $134bn globally by 2025.
The evening also included discussion of Scotland’s current strengths and future opportunities, as well as a presentation by Professor Dominiczak, Head of College and Mr Peter Silvester, Senior Vice President of Thermo Fisher Scientific.
The College’s recent UKRI Strength in Places bid – “The Living Laboratory - driving economic growth in Glasgow through real world implementation of Precision Medicine” was also a talking point throughout the event. If successful, the bid, in collaboration with industry partners, will create an internationally significant Precision Medicine campus integrated with the Queen Elizabeth University Hospital (QEUH) - the UK's largest hospital.
First published: 6 December 2019